IDO1 and schizophrenia: In ketamine-induced schizophrenia rat model the IDO inhibitor 1-methyl-D-tryptophan and the TDO inhibitor allopurinol prevented lipid peroxidation and increased superoxide dismutase and catalase activity in brain region specific manner (Table 4) [130].